Showing 7821-7830 of 18164 results for "".
Why Are There So Few Women in Neurosurgery?
https://reachmd.com/programs/clinicians-roundtable/why-are-there-so-few-women-in-neurosurgery/3449/More than half of all students accepted into medical schools are women, but only a fraction of neurosurgeons are female. Dr. Gail Rosseau, of the American Association of Neurological Surgeons, tells host Bruce Japsen about a new paper that highlights these challenges and provides recoAssessing Statin Prescriptions for Kids
https://reachmd.com/programs/clinicians-roundtable/assessing-statin-prescriptions-for-kids/3363/The American Academy of Pediatrics Report on Lipid Screening and Cardiovascular Health in Childhood, published in July 2008, triggered extensive discussion and debate among pediatricians. Dr. Sarah de Ferranti, director of the Preventive Cardiology Clinic at the Children's Hospital in Boston,&nKey Highlights from ECTRIMS 2024
https://reachmd.com/programs/neurofrontiers/key-highlights-from-ectrims-2024/26376/Hear from Dr. Mar Tintoré on what to expect from this year’s ECTRIMS conference.Postoperative Crohn’s Disease: Detecting Bile Acid Diarrhea
https://reachmd.com/programs/gi-insights/postoperative-crohns-disease-detecting-bile-acid-diarrhea/14617/How can the community-based clinician diagnose bile acid diarrhea?Non-Hormonal Options for Hot Flashes in the Post Menopausal Patient
https://reachmd.com/programs/clinicians-roundtable/non-hormonal-options-for-hot-flashes-in-the-post-menopausal-patient/7223/What is the practical approach in treating and counseling patients suffering from hot flashes? Dr. Susan Reed discusses the latest research on herbal supplements, such as black cohosh therapy; as well as, pharmacologic options: SSRIs, SNRIs and Gabapentin. Dr. Susan Reed is the Professor and DivisioHigh Myopia and Visual Disability: New Evidence from a Spanish Clinical Cohort
https://reachmd.com/programs/eye-on-ocular-health/high-myopia-and-visual-disability-new-evidence-from-a-spanish-clinical-cohort/36288/Targeting PI3Kα-Mutated HR+/HER2- Breast Cancer in the Second-Line Setting
https://reachmd.com/programs/project-oncology/targeting-pi3k-mutated-hrher2-breast-cancer-in-the-second-line-setting/35478/The second-line treatment of HR+/HER2-advanced breast cancer has evolved in recent years, particularly with the rise of biomarker-driven strategies targeting PI3Kα and other mutations. But given these advances, there’s a lot we need to think about when selecting therapy, like the differences betweenMastering Mutation-Driven mCRC: From Testing to Targeted Therapy
https://reachmd.com/programs/cme/mastering-mutation-driven-mcrc-from-testing-to-targeted-therapy/32374/Explore expert recommendations for optimizing clinical outcomes with targeted treatment combinations in BRAF-mutant mCRC.Tackling the Tripledemic: A Look at Combatting COVID-19, RSV, & the Flu
https://reachmd.com/programs/covid-19-frontlines/tackling-the-tripledemic-a-look-at-combatting-covid-19-rsv-the-flu/14228/Learn more about what we can do the manage the rising cases of COVID-19, RSV, and the flu.Bits from “Bullets and Brains”: The Challenge of Healing After a Headshot
https://reachmd.com/programs/book-club/bits-from-bullets-and-brains-the-challenge-of-healing-after-a-headshot/10721/A bullet to the brain is a condition that’s not easy to bounce back from, as this case of an almost-fatal shooting of a former congresswoman shows.